International Journal of Microbiology / 2020 / Article / Tab 1 / Research Article
Novel Antibiotic Combinations of Diverse Subclasses for Effective Suppression of Extensively Drug-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) Table 1 List of antibiotics tested against the MRSA isolate (LR-2).
Antibiotic Brand name Manufacturer Form Potency Final conc. Cephalosprin Cephradine (RAD) Velosef GlaxoSmithKline (GSK) IV 1 g 10 mg/ml Cefuroxime (CXM) Zinacef GlaxoSmithKline (GSK) IV 1.5 g 10 mg/ml Ceftazidime (CAZ) Fortum GlaxoSmithKline (GSK) IV 500 mg 10 mg/ml Cefotaxime (CTX) Claforan Sanofi-Aventis Pak Ltd. IV 1 g 10 mg/ml Ceftriaxone (CRO) Rocephin F.Hoffmann-La Roche Ltd. Tablets 1 g 10 mg/ml Cefepime (FEP) Maxipime GlaxoSmithKline (GSK) IV 1 g 10 mg/ml Aminoglycosides Amikacin (AK) Gracil Sami Pharmaceticals (Pvt.) Ltd. IV 500 mg/2 ml 10 mg/ml Gentamycin (CN) Genticyn Ray Pharma (Pvt.) Ltd. IV 80 mg/2 ml 10 mg/ml Tobramycin (TOB) Nebcin AGP Limited IV 80 mg/2 ml 10 mg/ml Fosfomycin (FOS) Monural Zambon Sachet 3 g 10 mg/ml Fluoroquinolones Ofloxacin (OFX) Oflobid Hilton Pharma (Pvt.) Ltd. Tablets 200 mg 10 mg/ml Levofloxacin (LVX) Leflox Getz Pharma Tablets 500 mg 10 mg/ml Sparfloxacin (SPX) Sparaxin Abbot Laboratories (Pak) Ltd. Tablets 100 mg 10 mg/ml Moxifloxacin (MOX) Avelox Bayer Pharma AG 10 mg/ml Carbapenem Meropenem (MEM) Meronem Pfizer Limited IV 500nmg 10 mg/ml Imipenem (IPM) Tienam Merck Sharp & Dohme Corp. (MSD) IV 500 mg 10 mg/ml Ampicillin + β -lactam Inhibitor Amoxicillin/clavulanic acid (AUG) Augmentin GlaxoSmithKline (GSK) Tablets 625 mg 10 mg/ml Piperacillin/tazobactam (TZP) Tanzo Bosch Pharmaceuticals (Pvt.) Ltd IV 4.5 g 10 mg/ml